Interferons in relapsing remitting multiple sclerosis: a systematic review.
about
Information provision for people with multiple sclerosisMitoxantrone for multiple sclerosisInterferon beta for secondary progressive multiple sclerosisInformation provision for persons with multiple sclerosisInterferon beta for secondary progressive multiple sclerosisOmega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosisNatalizumab: A new treatment for relapsing remitting multiple sclerosisRole of health-related quality of life measures in the routine care of people with multiple sclerosisWalking impairment in patients with multiple sclerosis: exercise training as a treatment option.Lifestyle, medication and socio-demographic determinants of mental and physical health-related quality of life in people with multiple sclerosis.Interferon-beta1a for the treatment of multiple sclerosis.Autologous hemopoietic stem cell transplantation for multiple sclerosis: is it worthwile?The Multiple Sclerosis Risk Sharing Scheme Monitoring Study--early results and lessons for the futurePersistence to disease-modifying therapies for multiple sclerosis in a Canadian cohort.Physical activity and quality of life in multiple sclerosis: intermediary roles of disability, fatigue, mood, pain, self-efficacy and social support.Data mining for response shift patterns in multiple sclerosis patients using recursive partitioning tree analysis.Is natalizumab a breakthrough in the treatment of multiple sclerosis?Targeting NOX enzymes in the central nervous system: therapeutic opportunities.Loss of AMPK exacerbates experimental autoimmune encephalomyelitis disease severity.Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis.Therapeutic strategies in childhood multiple sclerosisImmunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity.Azathioprine versus beta interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trialThe safety and efficacy of IFN-beta products for the treatment of multiple sclerosis.A randomized pilot study of naturopathic medicine in multiple sclerosisAssessing cost-effectiveness in the management of multiple sclerosis.When to initiate disease-modifying drugs for relapsing remitting multiple sclerosis in adults?AKP-11 - A Novel S1P1 Agonist with Favorable Safety Profile Attenuates Experimental Autoimmune Encephalomyelitis in Rat Model of Multiple SclerosisPharmacoeconomic considerations of multiple sclerosis therapy with the new disease-modifying agents.Disease-modifying drugs for the early treatment of multiple sclerosis.The diagnosis and management of multiple sclerosis.Antioxidants and polyunsaturated fatty acids in multiple sclerosis.Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave dreams study (brain venous drainage exploited against multiple sclerosis): study protocol for a randomized controlled trial.Association of Expanded Disability Status Scale and Cytokines after Intervention with Co-supplemented Hemp Seed, Evening Primrose Oils and Hot-natured Diet in Multiple Sclerosis Patients(♦).Social conflict exacerbates an animal model of multiple sclerosis.Justifying surgery's last taboo: the ethics of face transplantsBeta-interferon exposure and onset of secondary progressive multiple sclerosis.Advancement of therapies for neuroprotection in multiple sclerosis.Fumarates for the treatment of multiple sclerosis: potential mechanisms of action and clinical studies.The Association Between C424c/A Polymorphism Within the IL-25 Gene and Multiple Sclerosis.
P2860
Q24195040-31E4B26D-C1EA-4620-8037-1F3925AA1342Q24202866-943DB35F-62C9-4B1D-95FB-3D961DB941DFQ24203879-5BE41558-8C78-42A4-948C-B96969BA79DBQ24235042-5A2B009D-09C9-4E92-9978-ED287C4CF25EQ24240509-B6296FD3-D79A-40E4-82F3-25EEB761DB41Q24649574-8C0A5BE3-D846-4389-A288-552670917AA5Q24683014-7367BADE-135D-4CFC-88D8-44BB9C15386DQ24805196-4B76FB7E-A949-4E7E-AE22-E094BE11252AQ30433850-900D86A5-BF3A-47E7-91D5-7138D8016BDEQ30829510-315FC7DB-6B5E-4CD2-B3CA-30C5BD106968Q31106233-B750AEEB-B271-44D3-B207-28E6B24A066DQ33380269-296BB152-9F49-469C-AFF3-9BC634BB6EE8Q33397837-F7C8C6FB-AA40-4468-ADA2-C3472BADBA16Q33878804-E5B8B6FD-2F3F-45FF-9E38-D6C762AD0612Q33946060-63610CE8-ED8E-4507-B657-408CDF1B5D12Q34016835-FDF19941-26DF-403C-AAD4-F4C8464E1BDBQ34202547-F61C1E56-4B1F-45E5-A7D0-1D18F288042CQ34285497-67D5FF5B-5EBD-4C7D-A8A8-2EB861CB824EQ34291918-29E39378-55EC-4319-9A67-97F058EA1E14Q34307397-BBEF5D38-A2AF-422C-92C1-172593D26CDDQ34409508-FB6FB92E-C122-49B9-94B9-85E32788066DQ34448370-BFD1BE7D-91ED-42E1-941B-82E0E784C4B1Q34526979-87152959-BADB-464B-925C-FDF6F352F0E2Q34579232-4B67E0A6-0A3D-4FF6-BA1D-71B1DC2B7AFCQ35157941-3D0D779D-77DB-4DB4-92EF-2DE1BD8278BAQ35205463-BBA2CD02-119E-4529-AD1C-17994CF734B3Q35374052-7C05FE81-3BB5-44A1-A2CD-92568E09049EQ35826151-A443B823-24E1-4B81-92F9-F341753A00AFQ35906921-06875257-E30A-4357-BDE6-7CF796AF747EQ36106995-4043D553-3D72-4B42-89D2-0E58FD27AD61Q36228017-B902D856-1BAE-4460-99E2-51D9678C8E0AQ36239170-B8D6F3F8-9CA3-487A-8232-1976B27B316CQ36597127-74CF224C-32BA-41F9-BDD8-0B67C2B3898AQ36829238-542C57EC-9355-4823-997E-58BFD5CEFDE5Q36862803-DFA3226E-67E5-403D-99DB-E164B237B377Q37005190-1D144FE1-9BFE-4DD9-B0A5-00D9F9049FECQ37225075-D7B68A8C-0762-465E-9334-6E939D61F7C6Q37256701-0DAAEEB7-E0C1-4716-83BB-9C976CD906B6Q37318146-F74556DB-F985-4C96-987F-371A3F5DFD61Q37598008-18B78E9A-4C87-4568-8C6D-F3B02F575FED
P2860
Interferons in relapsing remitting multiple sclerosis: a systematic review.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Interferons in relapsing remitting multiple sclerosis: a systematic review.
@ast
Interferons in relapsing remitting multiple sclerosis: a systematic review.
@en
Interferons in relapsing remitting multiple sclerosis: a systematic review.
@nl
type
label
Interferons in relapsing remitting multiple sclerosis: a systematic review.
@ast
Interferons in relapsing remitting multiple sclerosis: a systematic review.
@en
Interferons in relapsing remitting multiple sclerosis: a systematic review.
@nl
prefLabel
Interferons in relapsing remitting multiple sclerosis: a systematic review.
@ast
Interferons in relapsing remitting multiple sclerosis: a systematic review.
@en
Interferons in relapsing remitting multiple sclerosis: a systematic review.
@nl
P2093
P1433
P1476
Interferons in relapsing remitting multiple sclerosis: a systematic review.
@en
P2093
Barbara Incorvaia
Chris Polman
George C Ebers
George P A Rice
Graziella Filippini
Luca Munari
P304
P356
10.1016/S0140-6736(03)12512-3
P407
P577
2003-02-01T00:00:00Z